302 related articles for article (PubMed ID: 24020910)
1. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent.
Brandi ML; Minisola S
Curr Med Res Opin; 2013 Nov; 29(11):1565-72. PubMed ID: 24020910
[TBL] [Abstract][Full Text] [Related]
2. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
Minisola S; Cianferotti L; Biondi P; Cipriani C; Fossi C; Franceschelli F; Giusti F; Leoncini G; Pepe J; Bischoff-Ferrari HA; Brandi ML
Osteoporos Int; 2017 Nov; 28(11):3239-3249. PubMed ID: 28815282
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D
Navarro-Valverde C; Sosa-Henríquez M; Alhambra-Expósito MR; Quesada-Gómez JM
J Steroid Biochem Mol Biol; 2016 Nov; 164():205-208. PubMed ID: 26829558
[TBL] [Abstract][Full Text] [Related]
6. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
8. Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome.
Zubillaga P; Garrido A; Mugica I; Ansa J; Zabalza R; Emparanza JI
Eur J Clin Nutr; 2006 May; 60(5):605-9. PubMed ID: 16391575
[TBL] [Abstract][Full Text] [Related]
9. Better functional mobility in community-dwelling elderly is related to D-hormone serum levels and to daily calcium intake.
Dukas L; Staehelin HB; Schacht E; Bischoff HA
J Nutr Health Aging; 2005; 9(5):347-51. PubMed ID: 16222401
[TBL] [Abstract][Full Text] [Related]
10. [Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis].
Rossini M; Viapiana O; Idolazzi L; Fracassi E; Gatti D; Adami S
Minerva Med; 2007 Feb; 98(1):53-68. PubMed ID: 17372582
[TBL] [Abstract][Full Text] [Related]
11. The pleiotropic effects of vitamin D in bone.
Anderson PH; Lam NN; Turner AG; Davey RA; Kogawa M; Atkins GJ; Morris HA
J Steroid Biochem Mol Biol; 2013 Jul; 136():190-4. PubMed ID: 22981997
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
Schacht E; Richy F; Reginster JY
J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study.
Sadlier DM; Magee CC
Clin Transplant; 2007; 21(6):683-8. PubMed ID: 17988259
[TBL] [Abstract][Full Text] [Related]
14. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.
Lau KH; Baylink DJ
Calcif Tissue Int; 1999 Oct; 65(4):295-306. PubMed ID: 10485982
[TBL] [Abstract][Full Text] [Related]
16. [Vitamin D: synthesis, metabolism, regulation, and an assessment of its deficiency in patients with chronic renal disease].
Spustová V; Dzúrik R
Vnitr Lek; 2004 Jul; 50(7):537-43. PubMed ID: 15323262
[TBL] [Abstract][Full Text] [Related]
17. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
18. [Metabolism of 25-hydroxyvitamin D3 and its regulation in rats during hypokinesis].
Sergeev IN; Arkhapchev IuP; Linberg LF; Blazheevich NV; Ushakov AS
Biokhimiia; 1984 Apr; 49(4):590-8. PubMed ID: 6329324
[TBL] [Abstract][Full Text] [Related]
19. [Effect of ascorbic acid on 25-hydroxyvitamin D3 metabolism in the kidneys and 1,25-dihydroxyvitamin D3 reception in the small intestine mucosa of guinea pigs].
Sergeev IN; Arkhapchev IuP; Kim RK; Kodentsova VM; Spirichev VB
Biokhimiia; 1987 Nov; 52(11):1867-74. PubMed ID: 2830915
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D: role and opportunity to prescribe.
Resmini G; Tarantino U; Iolascon G
Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S125-7. PubMed ID: 24046033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
